Developer docs
API playgroundTry for free, no card

Search company profiles

PainQx

Full company profile

uuid0003a5y

Namestring
PainQx
Legal namestring
PainQx, Inc.
Websiteurl
painqx.com
Company typeenum
Private
Founded yearint
2015
Short descriptiontext

PainQx is an AI-powered medical device company developing the ALGOS System, an objective pain measurement technology for chronic pain assessment serving healthcare providers, hospitals, and research institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
AI pain assessment, chronic pain measurement, medical device technology, objective pain quantification, pain monitoring algorithms
Industry4 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Device Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Government Research Contracts
TypeSubscription Recurring
Description

PainQx generates revenue through Small Business Innovation Research (SBIR) Phase II contract from the Defense Health Agency, valued at $1.5 million. This funding supports research, algorithm refinement, and FDA preparation activities.

biospace.com
Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

PainQx develops the ALGOS System, an AI-enabled pain assessment technology designed to objectively measure and monitor chronic pain in humans. The system uses proprietary machine learning algorithms to analyze pain-related data and produce quantified pain assessments, moving beyond subjective patient self-reporting. The company is conducting multi-site research and pursuing FDA regulatory preparation for commercialization as a medical device.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1ALGOS System
CategoryMedical Device Software
Description

An AI-enabled pain assessment technology designed to objectively quantify and monitor chronic pain in humans. The system uses proprietary machine learning algorithms to analyze pain-related data and produce measurable pain assessments, replacing subjective patient self-reporting. It is intended for use by medical professionals, hospitals, clinics, and research institutions.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Peers10 records
TypeDirect peer
Description

PainChek provides AI-powered pain assessment tools, primarily for patients who cannot self-report (e.g., dementia, non-verbal). It is directly comparable in using AI/ML to produce objective pain scores, though PainChek is more mature and commercially deployed in aged care.

TypeDirect peer
Description

Medasense develops the PMD-200 (NOL index), an objective AI-based pain monitoring technology used during surgery and critical care. It is the closest direct competitor to PainQx's ALGOS, addressing the same fundamental unmet need of objective pain quantification.

TypeBroad incumbent
Description

Masimo is a leading patient monitoring and medical technology company with multiple AI/ML-enabled measurement parameters. While focused on pulse oximetry and broader monitoring, it has the R&D scale and clinical channel to enter or compete in objective pain measurement.

TypeBroad incumbent
Description

SPR Therapeutics is a commercial-stage medical device company focused on peripheral nerve stimulation for chronic and acute pain. It is comparable as a pain-focused medical device company, though its approach is interventional rather than AI-based pain measurement.

TypeBroad incumbent
Description

Abbott operates a major neuromodulation business (Proclaim DRG, Proclaim XR) targeting chronic pain. It is a broad incumbent in the pain device space with the capital, regulatory infrastructure, and clinical reach to either compete with or acquire AI pain measurement technologies.

TypeBroad incumbent
Description

Boston Scientific has a sizable neuromodulation and pain management portfolio (including Vertiflex, WaveWriter, and other spinal cord stimulators). It is a broad incumbent in the chronic pain device market and a potential strategic acquirer of objective pain biomarkers.

TypeEmerging player
Description

Hinge Health is a digital MSK and chronic pain care platform combining exercise therapy, coaching, and (in some cases) AI-based motion tracking. It addresses chronic pain at scale, intersecting with PainQx's downstream objective measurement use case for treatment response.

8Sword Health
TypeEmerging player
Description

Sword Health is a digital MSK and pelvic health platform using AI to monitor patient movement and pain outcomes. It overlaps with PainQx in the chronic pain market and in using AI to quantify subjective clinical endpoints.

TypeEmerging player
Description

AppliedVR develops FDA-authorized virtual reality therapeutics for chronic pain, and the company uses pain outcome measurement as a core part of its value proposition. It is comparable as an emerging digital pain therapeutics player where pain measurement is mission-critical.

TypeEmerging player
Description

Curelator/StatLife develops data-driven platforms for tracking and predicting pain episodes (e.g., migraine) in individual patients. It is comparable to PainQx as an emerging player in AI/data-driven pain phenotyping, though focused on headache and patient-reported data.

Market position
Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PainQx

Medical Device Softwarepainqx.com

PainQx is an AI-powered medical device company developing the ALGOS System, an objective pain measurement technology for chronic pain assessment serving healthcare providers, hospitals, and research institutions.

PainQx firmographics

Firmographics
Name
PainQx
Legal name
PainQx, Inc.
Website
https://painqx.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
PainQx is an AI-powered medical device company developing the ALGOS System, an objective pain measurement technology for chronic pain assessment serving healthcare providers, hospitals, and research institutions.
Ownership category
akta.pro rank

PainQx industry classification

Industry
Product category
Medical Device Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • AI pain assessment
  • Chronic pain measurement
  • Medical device technology
  • Objective pain quantification
  • Pain monitoring algorithms

Where PainQx is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

PainQx business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations

Revenue model

  1. Government Research Contracts: PainQx generates revenue through Small Business Innovation Research (SBIR) Phase II contract from the Defense Health Agency, valued at $1.5 million. This funding supports research, algorithm refinement, and FDA preparation activities.

Go-to-market motion1 record

PainQx product offering

Product offering

Core offering

PainQx develops the ALGOS System, an AI-enabled pain assessment technology designed to objectively measure and monitor chronic pain in humans. The system uses proprietary machine learning algorithms to analyze pain-related data and produce quantified pain assessments, moving beyond subjective patient self-reporting. The company is conducting multi-site research and pursuing FDA regulatory preparation for commercialization as a medical device.

Differentiator

Problem solved

Functional benefit

Products and services

  • ALGOS System An AI-enabled pain assessment technology designed to objectively quantify and monitor chronic pain in humans. The system uses proprietary machine learning algorithms to analyze pain-related data and produce measurable pain assessments, replacing subjective patient self-reporting. It is intended for use by medical professionals, hospitals, clinics, and research institutions.

Companies that use PainQx

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

PainQx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature1 record

PainQx partnerships and signals

Strategic signal

Scale indicators1 record

PainQx competitors and assessment

Company assessment

Direct peers

  • PainChek: PainChek provides AI-powered pain assessment tools, primarily for patients who cannot self-report (e.g., dementia, non-verbal). It is directly comparable in using AI/ML to produce objective pain scores, though PainChek is more mature and commercially deployed in aged care.
  • Medasense Biometrics: Medasense develops the PMD-200 (NOL index), an objective AI-based pain monitoring technology used during surgery and critical care. It is the closest direct competitor to PainQx's ALGOS, addressing the same fundamental unmet need of objective pain quantification.

Broad incumbents

  • Masimo: Masimo is a leading patient monitoring and medical technology company with multiple AI/ML-enabled measurement parameters. While focused on pulse oximetry and broader monitoring, it has the R&D scale and clinical channel to enter or compete in objective pain measurement.
  • SPR Therapeutics: SPR Therapeutics is a commercial-stage medical device company focused on peripheral nerve stimulation for chronic and acute pain. It is comparable as a pain-focused medical device company, though its approach is interventional rather than AI-based pain measurement.
  • Abbott (Neuromodulation / Proclaim DRG): Abbott operates a major neuromodulation business (Proclaim DRG, Proclaim XR) targeting chronic pain. It is a broad incumbent in the pain device space with the capital, regulatory infrastructure, and clinical reach to either compete with or acquire AI pain measurement technologies.
  • Boston Scientific: Boston Scientific has a sizable neuromodulation and pain management portfolio (including Vertiflex, WaveWriter, and other spinal cord stimulators). It is a broad incumbent in the chronic pain device market and a potential strategic acquirer of objective pain biomarkers.

Emerging players

  • Hinge Health: Hinge Health is a digital MSK and chronic pain care platform combining exercise therapy, coaching, and (in some cases) AI-based motion tracking. It addresses chronic pain at scale, intersecting with PainQx's downstream objective measurement use case for treatment response.
  • Sword Health: Sword Health is a digital MSK and pelvic health platform using AI to monitor patient movement and pain outcomes. It overlaps with PainQx in the chronic pain market and in using AI to quantify subjective clinical endpoints.
  • AppliedVR: AppliedVR develops FDA-authorized virtual reality therapeutics for chronic pain, and the company uses pain outcome measurement as a core part of its value proposition. It is comparable as an emerging digital pain therapeutics player where pain measurement is mission-critical.
  • Curelator (now part of StatLife): Curelator/StatLife develops data-driven platforms for tracking and predicting pain episodes (e.g., migraine) in individual patients. It is comparable to PainQx as an emerging player in AI/data-driven pain phenotyping, though focused on headache and patient-reported data.

Market position

Customer concentration

PainQx social profiles

Digital presence

PainQx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PainQx leadership team

Management profile

Number of profiles

Profiles3 records

PainQx funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PainQx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PainQx

What does PainQx do?

PainQx develops the ALGOS System, an AI-enabled pain assessment technology designed to objectively measure and monitor chronic pain in humans. The system uses proprietary machine learning algorithms to analyze pain-related data and produce quantified pain assessments, moving beyond subjective patient self-reporting. The company is conducting multi-site research and pursuing FDA regulatory preparation for commercialization as a medical device.

Is PainQx a public or private company?

PainQx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PainQx founded?

PainQx was founded in 2015. It employs 1 to 10 people.

Where is PainQx based?

PainQx is headquartered in New York, United States, in the North America region.

How does PainQx make money?

One revenue line is on record: government Research Contracts.

Who are PainQx's main competitors?

Direct peers on record are PainChek and Medasense Biometrics. Broad incumbents are Masimo, SPR Therapeutics, Abbott (Neuromodulation / Proclaim DRG) and Boston Scientific. Emerging players are Hinge Health, Sword Health, AppliedVR and Curelator (now part of StatLife).

Does PainQx have an API?

No public API is recorded for PainQx.

What industry is PainQx in?

PainQx's product category is Medical Device Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals